收费全文 | 1328080篇 |
免费 | 112961篇 |
国内免费 | 6300篇 |
耳鼻咽喉 | 16668篇 |
儿科学 | 42864篇 |
妇产科学 | 36429篇 |
基础医学 | 182207篇 |
口腔科学 | 36231篇 |
临床医学 | 119536篇 |
内科学 | 275285篇 |
皮肤病学 | 31847篇 |
神经病学 | 109649篇 |
特种医学 | 55441篇 |
外国民族医学 | 274篇 |
外科学 | 209748篇 |
综合类 | 31446篇 |
一般理论 | 414篇 |
预防医学 | 105615篇 |
眼科学 | 27973篇 |
药学 | 93312篇 |
5篇 | |
中国医学 | 2150篇 |
肿瘤学 | 70247篇 |
2018年 | 13199篇 |
2017年 | 10528篇 |
2016年 | 12666篇 |
2015年 | 14153篇 |
2014年 | 19864篇 |
2013年 | 29652篇 |
2012年 | 36180篇 |
2011年 | 38831篇 |
2010年 | 24292篇 |
2009年 | 23832篇 |
2008年 | 36316篇 |
2007年 | 38728篇 |
2006年 | 39821篇 |
2005年 | 38437篇 |
2004年 | 36676篇 |
2003年 | 35747篇 |
2002年 | 33759篇 |
2001年 | 65961篇 |
2000年 | 67747篇 |
1999年 | 56274篇 |
1998年 | 15978篇 |
1997年 | 14205篇 |
1996年 | 15221篇 |
1995年 | 16153篇 |
1994年 | 15039篇 |
1993年 | 14073篇 |
1992年 | 47038篇 |
1991年 | 45735篇 |
1990年 | 43937篇 |
1989年 | 41784篇 |
1988年 | 38723篇 |
1987年 | 38054篇 |
1986年 | 35832篇 |
1985年 | 34619篇 |
1984年 | 26329篇 |
1983年 | 22060篇 |
1982年 | 13808篇 |
1981年 | 12405篇 |
1980年 | 11664篇 |
1979年 | 23505篇 |
1978年 | 17019篇 |
1977年 | 14323篇 |
1976年 | 13103篇 |
1975年 | 13660篇 |
1974年 | 16039篇 |
1973年 | 15360篇 |
1972年 | 14132篇 |
1971年 | 13007篇 |
1970年 | 11853篇 |
1969年 | 11082篇 |
Vaccination prevents severe morbidity and mortality from COVID-19 in the general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients with antibody deficiency is poorly understood.
ObjectivesCOVID-19 in patients with antibody deficiency (COV-AD) is a multi-site UK study that aims to determine the immune response to SARS-CoV-2 infection and vaccination in patients with primary or secondary antibody deficiency, a population that suffers from severe and recurrent infection and does not respond well to vaccination.
MethodsIndividuals on immunoglobulin replacement therapy or with an IgG less than 4 g/L receiving antibiotic prophylaxis were recruited from April 2021. Serological and cellular responses were determined using ELISA, live-virus neutralisation and interferon gamma release assays. SARS-CoV-2 infection and clearance were determined by PCR from serial nasopharyngeal swabs.
ResultsA total of 5.6% (n?=?320) of the cohort reported prior SARS-CoV-2 infection, but only 0.3% remained PCR positive on study entry. Seropositivity, following two doses of SARS-CoV-2 vaccination, was 54.8% (n?=?168) compared with 100% of healthy controls (n?=?205). The magnitude of the antibody response and its neutralising capacity were both significantly reduced compared to controls. Participants vaccinated with the Pfizer/BioNTech vaccine were more likely to be seropositive (65.7% vs. 48.0%, p?=?0.03) and have higher antibody levels compared with the AstraZeneca vaccine (IgGAM ratio 3.73 vs. 2.39, p?=?0.0003). T cell responses post vaccination was demonstrable in 46.2% of participants and were associated with better antibody responses but there was no difference between the two vaccines. Eleven vaccine-breakthrough infections have occurred to date, 10 of them in recipients of the AstraZeneca vaccine.
ConclusionSARS-CoV-2 vaccines demonstrate reduced immunogenicity in patients with antibody deficiency with evidence of vaccine breakthrough infection.
相似文献To examine cross-sectional associations between food insecurity and 12-month eating disorders, mood disorders, and anxiety disorders among U.S. adults.
MethodsThis study used data collected between 2001 and 2003 from 2914 participants in the National Comorbidity Survey-Replication, a nationally representative sample of U.S. adults (mean age = 44.9 years; 53.4% female). Twelve-month food insecurity was assessed with a modified version of the Short Form U.S. Household Food Security Scale. Twelve-month DSM-IV diagnoses of mental disorders were based on the World Health Organization Composite International Diagnostic Interview. Modified Poisson regression models were conducted, adjusting for age, sex, race/ethnicity, education, and income-to-poverty ratio.
ResultsFood insecurity was experienced by 11.1% of participants. Food insecurity was associated with greater prevalence of bulimic-spectrum eating disorders (prevalence ratio [PR] = 3.81; 95% confidence interval [CI] 2.26–6.42), mood disorders (PR = 2.53; 95% CI 1.96–3.29), and anxiety disorders (PR = 1.69; 95% CI 1.39–2.07).
ConclusionResults indicate that food insecurity is associated with a range of internalizing mental disorders, though these findings should be confirmed with contemporary data to reflect DSM-5 diagnostic updates and the economic effects of the COVID-19 pandemic. Findings from this study emphasize the need to expand food insecurity interventions and improve access to mental health services for food-insecure populations.
相似文献